Skip to main content
. 2021 Nov 5;11:21772. doi: 10.1038/s41598-021-01176-8

Table 3.

Spearman correlation analysis between the serum SERPINE1 antibody levels and clinical features.

Variable Spearman rank correlation coefficient (r) p value
Age 0.2308 < 0.0001
Height 0.0975 0.0037
Weight − 0.1306 0.0001
BMI − 0.0386 0.2562
Right IMT 0.2263 < 0.0001
Left IMT 0.1974 < 0.0001
Maximum IMT 0.2231 < 0.0001
AST − 0.0319 0.4139
ALT 0.0178 0.6488
ALP 0.0684 0.0934
LDH − 0.0028 0.9442
Tbil − 0.0798 0.043
CHE − 0.0537 0.239
γ-GTP 0.071 0.0794
TP − 0.0502 0.2058
ALB − 0.1083 0.0059
BUN 0.034 0.3841
Creatinine 0.032 0.413
eGFR − 0.0509 0.214
UA 0.0014 0.9753
AMY 0.0018 0.9722
T-CHO − 0.0251 0.5509
HDL-C − 0.0077 0.878
TG − 0.042 0.3827
Na 0.0491 0.2124
K − 0.0461 0.2417
Cl 0.0689 0.0801
CRP 0.0486 0.3003
WBC 0.1075 0.0058
RBC − 0.0962 0.0136
HGB − 0.0741 0.0575
HCT − 0.0762 0.0509
PLT − 0.0045 0.9075
Blood glucose 0.0804 0.0482
HbA1c 0.0304 0.5008
Smoking period 0.0372 0.3433
Alcohol frequency − 0.0402 0.326

A correlation analysis was performed to identify the relationship between SERPINE 1 antibody levels and the clinical features of the validation cohort.

Correlation coefficient (r) and p values were calculated using Spearman correlation analysis. Significant correlations are marked in bold.

BMI body mass index, IMT intima-media thickness, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, LDH lactate dehydrogenase, Tbil total bilirubin, CHE choline esterase, γ-GTP gamma-glutamyl transpeptidase, TP total protein, ALB albumin, BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, UA uric acid, AMY amylase, T-CHO total cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglyceride, CRP C-reactive protein, WBC white blood cell count, RBC red blood cell count, HCT hematocrit, PLT platelet count, HbA1c hemoglobin A1c.